Literature DB >> 4005874

Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker.

T Tsuruo, H Iida, S Tsukagoshi, Y Sakurai.   

Abstract

Mice inoculated with P388 leukemia were treated initially with vincristine (VCR) at a dose of either 1.5 or 2.0 mg/kg. After 1 week, VCR alone (0.1 mg/kg) was given daily for ten treatments, but no mice were cured with this regimen. However, when the calcium channel blocker verapamil (75 mg/kg) was administered with VCR at 1.5 or 2.0 mg/kg, lifespans were prolonged and one of ten or six of ten mice were cured, respectively. As reported previously, verapamil renders less sensitive or resistant tumor cells susceptible to VCR by inhibiting the VCR efflux mechanism, especially in resistant cells. Therefore, verapamil in combination with VCR apparently can result in total cell kill under the conditions used.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005874

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  6 in total

1.  Expressions of resistance and cross-resistance in teniposide-resistant L1210 cells.

Authors:  D Roberts; T Lee; E Parganas; L Wiggins; J Yalowich; R Ashmun
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Effects of 5,8-dideazaisopteroylglutamate (IAHQ) on L1210 leukemia in mice when given alone and in combination with methotrexate, probenecid, or verapamil.

Authors:  J B Hynes; A B Smith; G R Gale
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

3.  In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model.

Authors:  S Cros; N Guilbaud; M Berlion; T Dunn; G Regnier; A Dhainaut; G Atassi; J P Bizzari
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  A 22-kd protein (sorcin/V19) encoded by an amplified gene in multidrug-resistant cells, is homologous to the calcium-binding light chain of calpain.

Authors:  A M Van der Bliek; M B Meyers; J L Biedler; E Hes; P Borst
Journal:  EMBO J       Date:  1986-12-01       Impact factor: 11.598

5.  Establishment and characterization of resistant cells to etoposide (VP16) from a mouse breast cancer cell line, FM3A.

Authors:  E Takagi; H Kawatsu; K Shimokata; Y Nishiyama; K Kojima; S Yoshida
Journal:  Jpn J Cancer Res       Date:  1988-08

6.  Modulation of multidrug resistance by SDZ PSC 833 in leukemic and solid-tumor-bearing mouse models.

Authors:  T Watanabe; M Naito; T Oh-hara; Y Itoh; D Cohen; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1996-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.